Structural and functional profiles of the gut microbial community in polycystic ovary syndrome with insulin resistance (IR-PCOS): a pilot study

被引:118
作者
Zeng, Bo [1 ]
Lai, Zhiwen [1 ,2 ]
Sun, Lijin [3 ]
Zhang, Zhongbao [1 ]
Yang, Jianhua [1 ,4 ]
Li, Zaixin [1 ]
Lin, Jie [2 ]
Zhang, Zhi [1 ]
机构
[1] Sichuan Univ Sci & Engn, Dept Pharmaceut Engn, 180 Xueyuan St, Zigong 643000, Sichuan, Peoples R China
[2] Zigong Maternal & Child Hlth Care Hosp, Dept Reprod Med Ctr, 180 Xueyuan St, Zigong 643000, Sichuan, Peoples R China
[3] Zigong Maternal & Child Hlth Care Hosp, Coll Biol Engn, 180 Xueyuan St, Zigong 643000, Sichuan, Peoples R China
[4] Baylor Coll Med, Texas Childrens Canc Ctr, Dept Pediat, Houston, TX 77030 USA
关键词
Polycystic ovary syndrome; Insulin resistance; Gut microbial community; PREVALENCE; OBESITY; DYSBIOSIS;
D O I
10.1016/j.resmic.2018.09.002
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Polycystic ovary syndrome (PCOS) is a complex endocrine and metabolic disorder that affects 9-21% of reproductive-aged women. Affected women frequently display obesity, insulin resistance, and inflammation. Altered gut microbial community has been reported in PCOS and obese PCOS patients. However, the profile of the gut microbial community in insulin resistant PCOS (IR-PCOS) patients still remains unknown. In this study, next-generation sequencing based on the 16S rRNA gene was used to compare the gut microbial composition of women with IR-PCOS (n = 9, PCOS with insulin resistance), NIR-PCOS (n = 8, PCOS alone) and healthy controls (n = 8, HC). We assessed that the composition of the gut microbial communities in NIR-PCOS and IR-PCOS patients were significantly altered. The family Bacteroidaceae was prolific in the NIR-PCOS group and reached its highest level in the IR-PCOS group, while the Prevotellaceae dramatically decreased in PCOS patients, especially in the IR-PCOS group. Subsequent correlation analysis revealed that the increased clinical parameter levels, including insulin resistance, sex-hormones and inflammation, were positively associated with the abundance of Bacteroidaceae, but negatively associated with that of Prevotellaceae. In addition, IR-PCOS patients also displayed a significant difference in their amounts of Ruminococcaceae and Lachnospiraceae when compared to the NIR-PCOS group. Moreover, the functional prediction from PICRUSt revealed that 73 pathways are significantly changed in the gut microbial communities of PCOS patients. Specifically, 21 metabolism-associated pathways, including the steroid hormone biosynthesis and lipopolysaccharide biosynthesis pathways, are obviously changed in IR-PCOS when compared to NIR-PCOS and HC groups. Taking this into consideration, our present study suggests that the dysbiosis of gut microbial communities occurred most notably in IR-PCOS patients, and the difference in gut dysbiosis profile between the IR-PCOS and NIR-PCOS should be considered in clinical treatment for PCOS patients and future drugs development. (C) 2018 Institut Pasteur. Published by Elsevier Masson SAS. All rights reserved.
引用
收藏
页码:43 / 52
页数:10
相关论文
共 61 条
  • [1] Intestinal mucosal adherence and translocation of commensal bacteria at the early onset of type 2 diabetes: molecular mechanisms and probiotic treatment
    Amar, Jacques
    Chabo, Chantal
    Waget, Aurelie
    Klopp, Pascale
    Vachoux, Christelle
    Bermudez-Humaran, Luis G.
    Smirnova, Natalia
    Berge, Mathieu
    Sulpice, Thierry
    Lahtinen, Sampo
    Ouwehand, Arthur
    Langella, Philippe
    Rautonen, Nina
    Sansonetti, Philippe J.
    Burcelin, Remy
    [J]. EMBO MOLECULAR MEDICINE, 2011, 3 (09) : 559 - 572
  • [2] The Gut Microbiota Appears to Compensate for Seasonal Diet Variation in the Wild Black Howler Monkey (Alouatta pigra)
    Amato, Katherine R.
    Leigh, Steven R.
    Kent, Angela
    Mackie, Roderick I.
    Yeoman, Carl J.
    Stumpf, Rebecca M.
    Wilson, Brenda A.
    Nelson, Karen E.
    White, Bryan A.
    Garber, Paul A.
    [J]. MICROBIAL ECOLOGY, 2015, 69 (02) : 434 - 443
  • [3] Faecal microbiota profile of Crohn's disease determined by terminal restriction fragment length polymorphism analysis
    Andoh, A.
    Tsujikawa, T.
    Sasaki, M.
    Mitsuyama, K.
    Suzuki, Y.
    Matsui, T.
    Matsumoto, T.
    Benno, Y.
    Fujiyama, Y.
    [J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2009, 29 (01) : 75 - 82
  • [4] The prevalence and features of the polycystic ovary syndrome in an unselected population
    Azziz, R
    Woods, KS
    Reyna, R
    Key, TJ
    Knochenhauer, ES
    Yildiz, BO
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) : 2745 - 2749
  • [5] CONTROLLING THE FALSE DISCOVERY RATE - A PRACTICAL AND POWERFUL APPROACH TO MULTIPLE TESTING
    BENJAMINI, Y
    HOCHBERG, Y
    [J]. JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1995, 57 (01) : 289 - 300
  • [6] Metabolic endotoxemia initiates obesity and insulin resistance
    Cani, Patrice D.
    Amar, Jacques
    Iglesias, Miguel Angel
    Poggi, Marjorie
    Knauf, Claude
    Bastelica, Delphine
    Neyrinck, Audrey M.
    Fava, Francesca
    Tuohy, Kieran M.
    Chabo, Chantal
    Waget, Aurelie
    Delmee, Evelyne
    Cousin, Beatrice
    Sulpice, Thierry
    Chamontin, Bernard
    Ferrieres, Jean
    Tanti, Jean-Francois
    Gibson, Glenn R.
    Casteilla, Louis
    Delzenne, Nathalie M.
    Alessi, Marie Christine
    Burcelin, Remy
    [J]. DIABETES, 2007, 56 (07) : 1761 - 1772
  • [7] The Role of Gut Microbiota on Insulin Resistance
    Caricilli, Andrea M.
    Saad, Mario J. A.
    [J]. NUTRIENTS, 2013, 5 (03): : 829 - 851
  • [8] Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
    Chang, J
    Azziz, R
    Legro, R
    Dewailly, D
    Franks, S
    Tarlatzis, BC
    Fauser, B
    Balen, A
    Bouchard, P
    Dahlgren, E
    Devoto, L
    Diamanti, E
    Dunaif, A
    Filicori, M
    Homburg, R
    Ibanez, L
    Laven, J
    Magoffin, D
    Nestler, J
    Norman, RJ
    Pasquali, R
    Pugeat, M
    Strauss, J
    Tan, S
    Taylor, A
    Wild, R
    Wild, S
    Ehrmann, D
    Lobo, R
    [J]. FERTILITY AND STERILITY, 2004, 81 (01) : 19 - 25
  • [9] Gut Immune Maturation Depends on Colonization with a Host-Specific Microbiota
    Chung, Hachung
    Pamp, Suenje J.
    Hill, Jonathan A.
    Surana, Neeraj K.
    Edelman, Sanna M.
    Troy, Erin B.
    Reading, Nicola C.
    Villablanca, Eduardo J.
    Wang, Sen
    Mora, Jorge R.
    Umesaki, Yoshinori
    Mathis, Diane
    Benoist, Christophe
    Relman, David A.
    Kasper, Dennis L.
    [J]. CELL, 2012, 149 (07) : 1578 - 1593
  • [10] Will Gut Microbiota Help Design the Next Generation of GLP-1-Based Therapies for Type 2 Diabetes?
    Claus, Sandrine Paule
    [J]. CELL METABOLISM, 2017, 26 (01) : 6 - 7